Esta página todavía está en inglés. Las páginas principales ya están en español.
Represents
Declarations, newest first
- SF 2312 Relating to manufacturers and distributors of 340B drugsAgainstfor Genentech, Inc., A Member of the Roche Group · February 13, 2026
- HSB 591 Establishing the medical spa oversight Act, and making penalties applicableForfor Genentech, Inc., A Member of the Roche Group · January 23, 2026
- HF 2010 Relating to the advertising of prescription drugs and vaccines and providing civil penalti…Againstfor Genentech, Inc., A Member of the Roche Group · January 13, 2026
- HF 2009 Relating to manufacturers and distributors of 340B drugsAgainstfor Genentech, Inc., A Member of the Roche Group · January 13, 2026
- SF 383 Relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy servi…Forfor Genentech, Inc., A Member of the Roche Group · April 3, 2025
- HF 852 Relating to pharmacy benefits managers, pharmacies, and prescription drugs and including a…Forfor Genentech, Inc., A Member of the Roche Group · March 10, 2025
- SSB 1074 Relating to pharmacy benefits managers, pharmacies, and prescription drugs and including a…Forfor Genentech, Inc., A Member of the Roche Group · February 5, 2025
- HSB 99 Relating to pharmacy benefits managers, pharmacies, and prescription drugs and including a…Forfor Genentech, Inc., A Member of the Roche Group · February 5, 2025
- HF 2668 Relating to insurance coverage for biomarker testingForfor Genentech, Inc., A Member of the Roche Group · March 20, 2024
- SF 2381 Relating to certain cost controls for health care servicesAgainstfor Genentech, Inc., A Member of the Roche Group · February 16, 2024
- SF 431 Relating to certain cost controls for health care services, and including penaltiesAgainstfor Genentech, Inc., A Member of the Roche Group · January 31, 2024
- HF 2157 Relating to insurance coverage for biomarker testingUndecidedfor Genentech, Inc., A Member of the Roche Group · January 27, 2024
- HF 626 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · January 23, 2024
- HF 225 Relating to the right to try ActUndecidedfor Genentech, Inc., A Member of the Roche Group · March 1, 2023
- HF 287 Creating a rare disease advisory councilForfor Genentech, Inc., A Member of the Roche Group · February 21, 2023
- HF 282 Relating to the management of soil and water resources, by providing for certain practices…Withdrawnfor Genentech, Inc., A Member of the Roche Group · February 21, 2023
- HF 282 Relating to the management of soil and water resources, by providing for certain practices…Forfor Genentech, Inc., A Member of the Roche Group · February 16, 2023
- SF 262 Relating to consumer data protection, providing civil penalties, and including effective d…Undecidedfor Genentech, Inc., A Member of the Roche Group · February 14, 2023
- HF 96 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · February 6, 2023
- SF 86 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · February 6, 2023
- SSB 1071 SSB 1071Undecidedfor Genentech, Inc., A Member of the Roche Group · January 26, 2023
- HSB 12 HSB 12Undecidedfor Genentech, Inc., A Member of the Roche Group · January 26, 2023
- HF 2539 Relating to the newborn screeningForfor Genentech, Inc., A Member of the Roche Group · March 1, 2022
- SF 2345 Relating to the newborn screeningForfor Genentech, Inc., A Member of the Roche Group · February 23, 2022
- SF 2208 Relating to consumer data protection, making penalties applicable, and including effective…Undecidedfor Genentech, Inc., A Member of the Roche Group · February 10, 2022
- HSB 674 HSB 674Undecidedfor Genentech, Inc., A Member of the Roche Group · February 10, 2022
- HSB 690 HSB 690Forfor Genentech, Inc., A Member of the Roche Group · February 9, 2022
- SSB 3122 SSB 3122Forfor Genentech, Inc., A Member of the Roche Group · February 9, 2022
- HF 2203 Relating to health care including protections for health care providers against disciplina…Undecidedfor Genentech, Inc., A Member of the Roche Group · February 2, 2022
- HF 2199 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · February 2, 2022
- SF 2117 Relating to experimental treatments for terminally ill persons, and including effective da…Undecidedfor Genentech, Inc., A Member of the Roche Group · January 27, 2022
- HF 2010 Relating to experimental treatments for terminally ill persons, and including effective da…Undecidedfor Genentech, Inc., A Member of the Roche Group · January 20, 2022
- HF 526 Relating to price transparency and cost-sharing for prescription drugs, and including appl…Undecidedfor Genentech, Inc., A Member of the Roche Group · March 4, 2021
- HF 372 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · February 19, 2021
- HF 178 Prohibiting employers and employment agencies from seeking the criminal record or criminal…Forfor Genentech, Inc., A Member of the Roche Group · February 17, 2021
- SF 125 Relating to immunization information requested on a medical examiner investigation formAgainstfor Genentech, Inc., A Member of the Roche Group · February 4, 2021
- HSB 46 HSB 46Undecidedfor Genentech, Inc., A Member of the Roche Group · January 20, 2021
- SF 2383 Establishing an interim study committee to review and evaluate continuity of care and nonm…Undecidedfor Genentech, Inc., A Member of the Roche Group · March 2, 2020
- SF 2384 Relating to insurance coverage for prescription drugs used in the treatment of stage IV ca…Forfor Genentech, Inc., A Member of the Roche Group · February 25, 2020
- HF 2253 Relating to price transparency for prescription drugs sold in this state, and including ap…Undecidedfor Genentech, Inc., A Member of the Roche Group · February 18, 2020
- SF 2216 Relating to insurance coverage for diagnostic breast cancer examinations and prescription …Forfor Genentech, Inc., A Member of the Roche Group · February 13, 2020
- SSB 3161 SSB 3161Forfor Genentech, Inc., A Member of the Roche Group · February 13, 2020
- HF 2089 Relating to continuity of care and nonmedical switching by health carriers, health benefit…Forfor Genentech, Inc., A Member of the Roche Group · January 29, 2020
- HF 2084 Relating to the adoption of the interstate curing disease compactUndecidedfor Genentech, Inc., A Member of the Roche Group · January 28, 2020